v3.26.1
SEGMENT REPORTING (Tables)
 6 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The following table presents the OPTAVIA segment's revenue, significant segment expenses, and segment net income (loss) for the three months ended June 30, 2026 and 2025, respectively:

June 30, 2026June 30, 2025
Revenue$76,384$105,555
Less:
Cost of sales22,988 28,911 
Selling, marketing, and after sales support34,739 50,485 
Distribution4,496 5,305 
Technology8,574 10,566 
Administrative and corporate support functions8,096 8,685 
Equity compensation1,818 2,669 
Other income (1)
(1,336)(3,941)
Provision for income taxes109 395 
Segment net income (loss)$(3,100)$2,480 
Reconciliation of profit or loss
Adjustments and reconciling items— — 
Consolidated net income (loss)$(3,100)$2,480 
(1) Other loss income included within Segment net income (loss) includes interest income, interest expense, and gains and losses on LifeMD common stock.
The following table presents the OPTAVIA segment's revenue, significant segment expenses, and segment net income for the six months ended June 30, 2026 and 2025, respectively:
June 30, 2026June 30, 2025
Revenue$152,428$221,283
Less:
Cost of sales47,27660,395
Selling, marketing, and after sales support69,420110,340
Distribution7,9499,831
Technology17,88621,608
Administrative and corporate support functions13,80516,667
Equity compensation3,7144,771
Other income (1)
(2,690)(5,730)
Provision for income taxes2901,693
Segment net income (loss)$(5,222)$1,708
Reconciliation of profit or loss
Adjustments and reconciling items— — 
Consolidated net income (loss)
$(5,222)$1,708
(1) Other income included within Segment net income includes interest income, interest expense, and gains and losses on LifeMD common stock.